Argent Biopharma LtdASX: RGT

Notification of cessation of securities - RGT

Sep 1, 2026 at 4:06 AM EDT · Issued by Argent Biopharma Ltd via ASX

Filed with ASX · Sep 1, 2026 at 4:06 AM EDT · 5 pages · English

On 6ix: 6ix.com/news/notification-of-cessation-of-securities-rgt

Release

Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 1 / 5 Announcement Summary Entity name ARGENT BIOPHARMA LIMITED Announcement Type New announcement Date of this announcement Tuesday September 01, 2026 Details of +securities that...

Argent Biopharma Ltd on 6ix

Earlier from Argent Biopharma

Appendix 4E and 2026 Annual ReportAug 31
Appendix 4G and Corporate Governance StatementAug 31
FDA-CVM Establish INAD File for CannEpil Veterinary ProgramAug 25
Proposed issue of securities - RGTAug 10
$250,000 in Funding Received under Financing FacilityAug 10

Later from Argent Biopharma

Argent Signs NLC Licence to Expand Antiviral PortfolioSep 28
Execution of Loan Facility AgreementSep 30
Application for quotation of securities - RGTOct 2
Strategic Focus on Immune Modulation and LongevityOct 11
Date of AGM and Closing Date for Director NominationsOct 14

All Argent Biopharma news releases

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma